Biopharma Has No Choice But To Comply With Price Controls

Forbes November 8, 2023
John LaMattina

There is no doubt that the American people endorse the concept of the U.S. government controlling the prices of drugs. With the passage of the Inflation Reduction Act (IRA), this is now reality for the biopharma industry. However, Health and Human Services Secretary Xavier Becerra is trying to make it seem that companies are not being forced into anything. Witness his recent comments at the Milken Future of Health Summit.

“No one is captive in this negotiation. If any of those drug makers don’t wish to negotiate, they’re not required to. They are asked to participate….if they want access to the 65 million Americans who have Medicare.”

This is a pretty cavalier attitude to what is going to happen to...

Today's Sponsors

Today's Sponsor